Concepedia
Statistics
Publications
24
Citations
4.3K
H-Index
20
Active since
1977
Affiliations
University of California, Berkeley(Current)
Aduro BioTech (United States)
Lawrence Berkeley National Laboratory
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
David B. Kanne is an author at University of California, Berkeley specializing in oncology, life sciences, and cancer immunology.
Publications per year
1977–2018
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter et al. · Cell Reports · 2015 · 1.5K citations · Full text
Medicine, Immunology, Oncology +17
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
Juan Fu, David B. Kanne, Meredith L. Leong et al. · Science Translational Medicine · 2015 · 700 citations
Medicine, Oncology, Pharmacology +16
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
Kelsey E. Sivick, Anthony L. Desbien, Laura Hix Glickman et al. · Cell Reports · 2018 · 438 citations · Full text
Life Sciences, Immunology, Oncology +17
Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors
Jason R. Baird, David J. Friedman, Benjamin Cottam et al. · Cancer Research · 2015 · 245 citations
The psoralen-DNA photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5',8-trimethylpsoralen
David B. Kanne, Kenneth Straub, Henry Rapoport et al. · Biochemistry · 1982 · 194 citations · Full text
Natural Sciences, Biochemistry, Bioorthogonal Chemistry +7
1–5 of 24